A Drug Utilization Study of Xofigo Use in Sweden
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 01 Jun 2017
At a glance
- Drugs Radium 223 chloride (Primary)
- Indications Bone metastases; Prostate cancer
- Focus Therapeutic Use
- Sponsors Bayer
- 14 Mar 2016 Planned End Date changed from 1 Jun 2016 to 1 Dec 2017, according to ClinicalTrials.gov record.
- 14 Mar 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Dec 2017, according to ClinicalTrials.gov record.
- 11 Feb 2016 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.